SNDX logo
SNDX

Syndax Pharmaceuticals Inc

Biotechnology

Syndax Pharmaceuticals Inc (SNDX) Earnings

Last reported
April 30, 2026
EPS estimate
-$0.63
EPS actual
Revenue est.
$72.8M
Revenue actual